Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during wallerian degeneration

Molecular and Cellular Neuroscience

Volumn 24, Issue 3, 2003, Pages 753-765

  De, Susna ^a   Trigueros, Marcelino Avilés ^a,b   Kalyvas, Athena ^a   David, Samuel ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; PHOSPHOLIPASE A2; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYLTRIFLUOROMETHANE; ENZYME INHIBITOR; GROUP II SECRETORY PHOSPHOLIPASE A2; PHOSPHOLIPASE A; PHOSPHOLIPASE A2 ALPHA; PHOSPHOLIPASE A2-ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; EMBRYO; ENZYME INHIBITION; ENZYME RELEASE; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; MOUSE MUTANT; NERVE DEGENERATION; NERVE TRANSECTION; NONHUMAN; OPTIC NERVE INJURY; PERIPHERAL NERVE INJURY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; ELECTRON MICROSCOPY; ENZYMOLOGY; GENETICS; MUTATION; MYELIN SHEATH; NERVE FIBER; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCIATIC NEUROPATHY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

WALLERIA;

ANIMALS; ARACHIDONIC ACIDS; AXONS; ENZYME INHIBITORS; FEMALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON; MUTATION; MYELIN SHEATH; OPTIC NERVE INJURIES; PHAGOCYTOSIS; PHOSPHOLIPASES A; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NEUROPATHY; WALLERIAN DEGENERATION;

EID: 0344305407     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00241-0     Document Type: Article

References (67)

1. Bähr M., Przyrembel C. Myelin from peripheral and central nervous system is a nonpermissive substrate for retinal ganglion cell axons. Exp. Neurol. 134:1995;87-93.
2. Bandtlow C.E., Schwab M.E. NI-35/250/Nogo-A a neurite growth inhibitor restricting structural plasticity and regeneration of nerve fibers in the adult vertebrate CNS . Glia. 29:2000;175-181.
3. 2 in normal and ras-transformed cells. J. Cell Biol. 106:1988;1649-1658.
4. Be'eri H., Reichert F., Saada A., Rotshenker S. The cytokine network of Wallerian degeneration IL-10 and GM-CSF . Eur. J. Neurosci. 10:1998;2707-2713.
5. Beller D.I., Springer T.A., Schreiber R.D. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J. Exp. Med. 156:1982;1000-1009.
6. Beuche W., Friede R.L. The role of non-resident cells in Wallerian degeneration. J. Neurocytol. 13:1984;767-796.
7. Beuche W., Friede R.L. Myelin phagocytosis in Wallerian degeneration of peripheral nerves depends on silica-sensitive, bg/bg-negative and Fc-positive monocytes. Brain Res. 378:1986;97-106.
8. Bigbee J.W., Yoshino J.E., De Vries G.H. Morphological and proliferative responses of cultured Schwann cells following rapid phagocytosis of a myelin-enriched fraction. J. Neurocytol. 16:1987;487-496.
9. Bignami A., Dahl D., Nguyen B.T., Crosby C.J. The fate of atonal debris in Wallerian degeneration of rat optic and sciatic nerve. J. Neuropathol. Exp. Neurol. 40:1981;537-550.
10. Bisby M.A., Chen D. Delayed Wallerian degeneration in sciatic nerves of C57BL/Ola mice is associated with impaired regeneration of sensory axons. Brain Res. 530:1990;117-120.
11. Brück W. The role of macrophages in Wallerian degeneration. Brain Pathol. 7:1997;741-752.
12. Brück W., Friede R.L. Anti-CR3 antibody blocks myelin phagocytosis by macrophages in vitro. Acta Neuropathol. 80:1990;415-418.
13. Brück W., Friede R.L. The role of complement in myelin phagocytosis during PNS Wallerian degeneration. J. Neurol. Sci. 103:1991;182-187.
14. Brück W., Hutinga I., Dijkstra C.D. Liposome-mediated monocyte depletion during Wallerian degeneration defines the role of hematogenous phagocytes in myelin removal. J. Neurosci. Res. 46:1996;477-484.
15. Brück W., Maruschak B., Friede R.L. Mechanisms of macrophage recruitment in Wallerian degeneration. Acta Neuropathol. 89:1995;363-367.
16. Bunt G., de Wit J., van den Bosch H., Verkleij A.J., Boonstra J. Ultrastructural localization of cPLA2 in unstimulated and EGF/A23187-stimulated fibroblasts. J. Cell Sci. 110:1997;2449-2459.
17. S mice. J. Neuropathol. Exp. Neurol. 57:1998;915-930.
18. Castano A., Bell M.D., Perry V.H. Unusual aspects of inflammation in the nervous system Wallerian degeneration . Neurobiol. Aging. 17:1996;745-751.
19. Conforti L., Tarlton A., Mack T.G., Mi W., Buckmaster E.A., Wagner D., Perry V.H., Coleman M.P. A Ufd2/D4Cole 1 e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (Wld) mouse. Proc. Natl. Acad. Sci. USA. 97:2000;11377-11382.
20. Crang A.J., Blakemore W.F. Observations on Wallerian degeneration in explant cultures of cat sciatic nerve. J. Neurocytol. 15:1986;471-482.
21. Dailey A.T., Avellino A.M., Benthen L., Silver J., Kliot M. Complement depletion reduces macrophage infiltration and activation during Wallerian degeneration and axonal regeneration. J. Neurosci. 18:1998;6713-6722.
22. David S., Braun P.E., Jackson D.L., Kottis V., McKerracher L. Laminin overrides the inhibitory effects of peripheral nervous system and central nervous system myelin-derived inhibitors of neurite growth. J. Neurosci. Res. 42:1995;594-602.
23. David S., Lacroix S. Molecular approaches to spinal cord repair. Annu. Rev. Neurosci. 26:2003;411-440.
24. David, S., Ousman, S., 2001. Stimulating immune system-central nervous system interactions to promote long distance axon regeneration, in: Aldskogius, H., Fraher, J. (Eds), Glial Interfaces in the Nervous System: Role in Repair and Plasticity, IOS Press, pp, 153-161.
25. 2. J. Biol. Chem. 269:1994;13057-13060.
26. Fernandez-Valle C., Bunge R.P., Bunge M.B. Schwann cells degrade myelin and proliferate in the absence of macrophages evidence from in vitro studies of Wallerian degeneration . J. Neurocytol. 24:1995;667-679.
27. Fujimoto K., Umeda M., Fujimoto T. Transmembrane phospholipid distribution revealed by freeze-fracture replica labeling. J. Cell Sci. 109:1996;2453-2460.
28. George E.B., Glass J.D., Griffin J.W. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J. Neurosci. 15:1995;6445-6452.
29. George R., Griffin J.W. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system the dorsal radiculotomy model . Exp. Neurol. 129:1994;225-236.
30. 2 enzymes selective inhibitors and their pharmacological potential . Adv. Pharmacol. 12:1995;31-66.
31. Griffin J.W., George R., Lobato C., Tyor W.R., Yan L.C., Glass J.D. Macrophage responses and myelin clearance during Wallerian degeneration relevance to immune-mediated demyelination . J. Neuroimmunol. 40:1992;153-166.
32. Griffin J.W., Hoffman P.N. Degeneration and regeneration in the peripheral nervous system. Dyck P.J., Thomas P.K., Griffin J.W., Low P.A., Podulso J.F. Peripheral Neuropathy. 1993;361-376 Saunders, Philadelphia.
33. Hack C.E., Wolbink G.J., Schalkwijk C., Speijer H., Hermens W.T., van den Bosch H. A role for secretory phopholipase A2 and C-reactive protein in the removal of injured cells. Immunol. Today. 18:1997;111-115.
34. Hall S.M. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J. Cell Sci. 10:1972;535-546.
35. S mice in the presence of recruited macrophages. J. Neurocytol. 22:1993;480-490.
36. Hall S.M., Gregson N. The in vivo and ultrastructural effects of injection of lysophosphatidylcholine into myelintated peripheral nerve fibers of the adult mouse. J. Cell Sci. 9:1971;769-789.
37. Jeffery N.D., Blakemore W.F. Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J. Neurocytol. 24:1995;775-781.
38. Kasckow J.W., Abood L.G., Hoss W., Herndon R.M. Mechanism of phospholipase A2-induced conduction block in bullfrog sciatic nerve. I. Electrophysiology and morphology. Brain Res. 373:1986;384-391.
39. 2 gene in inbred mouse strains. J. Biol. Chem. 270:1995;22378-22385.
40. Lawson L.J., Frost L., Risbridger J., Fearn S., Perry V.H. Quantification of the mononuclear phagocytic response to Wallerian degeneration of the optic nerve. J. Neurocytol. 23:1994;729-744.
41. Liu K.M., Shen C.L. Ultrastructural sequence of myelin breakdown during Wallerian degeneration in the rat optic nerve. Cell Tissue Res. 242:1985;245-256.
42. Liu L., Persson J.K.E., Svensson M., Aldskogius H. Glial cell responses, complement and clustrin in the central nervous system following dorsal root transection. Glia. 23:1998;221-238.
43. Lunn E.R., Perry V.H., Brown M.C., Rosen H., Gordon S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1:1989;27-33.
44. Müller H.W., Minwegen P. Nonresident macrophages in peripheral nerve of rat effect of silica on migration, myelin phagocytosis, and apolipoprotein E expression during Wallerian degeneration . J. Neurosci. Res. 18:1987;222-229.
45. 2. Crit. Rev. Immunol. 17:1997;225-283.
46. Ousman S., David S. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia. 30:2000;92-104.
47. Ousman S., David S. MIP-1α, MCP-1, GM-CSF and TNFα control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J. Neurosci. 21:2001;4649-4656.
48. Paul J.A., Gregson N.A. An immunohistochemical study of phospholipase A2 in peripheral nerve during Wallerian degeneration. J. Neuroimmunol. 39:1992;31-48.
49. Perry V.H., Brown M.C., Gordon S. The macrophage response to central and peripheral nerve injury a possible role for macrophages in regeneration . J. Exp. Med. 165:1987;1218-1223.
50. Perry V.H., Brown M.C., Lunn E.R. Very slow retrograde and Wallerian degeneration the CNS of C57BL/Ola mice. Eur. J. Neurosci. 3:1991;102-105.
51. Perry V.H., Brown M.C., Lunn E.R., Tree P., Gordon S. Evidence that very slow Wallerian degeneration in C57BL/Ola mice is an intrinsic property of the peripheral nerve. Eur. J. Neurosci. 2:1990;802-808.
52. Perry V.H., Tsao J.W., Fearn S., Brown M.C. Radiation-induced reductions in macrophage recruitment have only slight effects on myelin degeneration in sectioned peripheral nerves of mice. Eur. J. Neurosci. 7:1995;271-280.
53. Rotshenker, S., 2001. Co-operation between Schwann cells, fibroblasts and macrophages after axonal injury: a prelude to successful regeneration, in: Aldskogius, H., Fraher, J. (Eds.), Glial Interfaces in the Nervous System: Role in Repair and Plasticity, IOS Press, pp. 3-12.
54. Rotshenker S., Aamar S., Barak V. Interleukin-1 activity in lesioned peripheral nerve. J. Neuroimmunol. 39:1992;75-80.
55. Rutkowski J.L., Tuite G.F., Lincoln P.M., Boyer P.J., Tennekoon G.I., Kunkel S.L. Signals for proinflammatory cytokine secretion by human Schwann cells. J. Neuroimmunol. 101:1999;47-60.
56. Saada A., Reichert F., Rotshenker S. Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of Mac-2 by macrophages and Schwann cells. J. Cell Biol. 133:1996;159-167.
57. Shamash S., Reichert F., Rotshenker S. The cytokine network of Wallerian degeneration tumor necrosis factor-α, interleukin-1α, and interleukin-1β J. Neurosci. 22:2002;3052-3060.
58. S mice with delayed Wallerian degeneration differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity . Brain Res. 784:1998;154-162.
59. Stoll G., Griffin J.W., Li C.Y., Trapp B.D. Wallerian degeneration in the peripheral nervous system participation of both Schwann cells and macrophages in myelin degradation . J. Neurocytol. 18:1989;671-683.
60. Stoll G., Trapp B.D., Griffin J.W. Macrophage function during Wallerian degeneration of rat optic nerve clearance of degenerating myelin and Ia expression . J. Neurosci. 9:1989;2327-2335.
61. Street I.P., Lin H.K., Laliberte F., Ghomashchi F., Wang Z., Perrier H., Trembley N.M., Huang Z., Weech P.K., Gelb M.H. Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry. 32:1993;5935-5940.
62. Trimble L.A., Street I.P., Perrier H., Trembley N.M., Weech P.K., Bernstein M.A. NMR structural studies of the tight complex between a trifluoromethyl ketone inhibitor and the 85-kDa human phospholipase A2. Biochemistry. 32:1993;12560-12565.
63. Volanakis J.E., Wirtz K.W.A. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature. 281:1979;155-157.
64. Vougioukas V.I., Roeske S., Michel U., Brück W. Wallerian degeneration in ICAM-1-deficient mice. Am. J. Pathol. 152:1998;241-249.
65. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primary fibers. Phil. Trans. R. Soc. London (Biol.). 140:1850;423-429.
66. Wang M.S., Wu Y., Culver D.G., Glass J.D. Pathogenesis of axonal degeneration parallels between Wallerian degeneration and vincristine neuropathy . J. Neuropathol. Exp. Neurol. 59:2000;599-606.
67. Williams P.L., Hall S.M. Chronic Wallerian degeneration an in vivo and ultrastructural study . J. Anat. 109:1971;487-503.